Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension.

Tousoulis D, Androulakis E, Papageorgiou N, Miliou A, Chatzistamatiou E, Oikonomou E, Moustakas G, Kallikazaros I, Stefanadis C.

Am J Hypertens. 2013 May;26(5):683-90. doi: 10.1093/ajh/hps089. Epub 2013 Mar 11.

PMID:
23479071
2.

Genetic background of left ventricular hypertrophy in Uzbek hypertensive men.

Kurbanova D, Eliseyeva M.

Turk Kardiyol Dern Ars. 2010 Oct;38(7):466-72.

3.

Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients.

Wang AY, Chan JC, Wang M, Poon E, Lui SF, Li PK, Sanderson J.

Kidney Int. 2003 May;63(5):1899-907.

4.

Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.

Sakuragi S, Ichikawa K, Yamada K, Tanimoto M, Miki T, Otsuka H, Yamamoto K, Kawamoto K, Katayama Y, Tanakaya M, Ito H.

Int J Cardiol. 2015;190:287-92. doi: 10.1016/j.ijcard.2015.04.189. Epub 2015 Apr 24.

PMID:
25932809
5.

Angiotensinogen M235T polymorphism and left ventricular indices in treated hypertensive patients with normal coronary arteries.

Olcay A, Nişanci Y, Ekmekçi CG, Ozbek U, Sezer M, Umman B, Buğra Z.

Anadolu Kardiyol Derg. 2007 Sep;7(3):257-61.

6.

Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.

Alves GB, Oliveira EM, Alves CR, Rached HR, Mota GF, Pereira AC, Rondon MU, Hashimoto NY, Azevedo LF, Krieger JE, Negrão CE.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):487-92. doi: 10.1097/HJR.0b013e32832c5a8a.

PMID:
19404196
7.

Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy.

Malmqvist K, Wallén HN, Held C, Kahan T.

J Hypertens. 2002 Aug;20(8):1563-9.

PMID:
12172318
8.

Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2.

Isaji M, Mune T, Takada N, Yamamoto Y, Suwa T, Morita H, Takeda J, White PC.

J Hypertens. 2005 Jun;23(6):1149-57.

PMID:
15894890
9.

Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study.

Tang W, Devereux RB, Rao DC, Oberman A, Hopkins PN, Kitzman DW, Arnett DK.

Am Heart J. 2002 May;143(5):854-60.

PMID:
12040348
10.

Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes.

Karjalainen J, Kujala UM, Stolt A, Mäntysaari M, Viitasalo M, Kainulainen K, Kontula K.

J Am Coll Cardiol. 1999 Aug;34(2):494-9.

11.

Cystatin C and cardiac hypertrophy in primary hypertension.

Prats M, Font R, Bardají A, Gutierrez C, Lalana M, Vilanova A, Martinez-Vea A.

Blood Press. 2010 Feb;19(1):20-5. doi: 10.3109/08037050903416386.

PMID:
20113216
12.

[Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].

Franchi F, Michelucci A, Padeletti L, Monopoli A, Fabbri G, Cersosimo RM, Mezzani A.

G Ital Cardiol. 1992 Aug;22(8):905-18. Italian.

PMID:
1478391
13.

Association between functional polymorphisms of renin-angiotensin system, left ventricular mass, and geometry over 4 years in a healthy Chinese population aged 60 years and older.

Lin TH, Chiu HC, Lee YT, Su HM, Voon WC, Liu HW, Lai WT, Sheu SH.

J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1157-63.

PMID:
17921431
14.
16.

Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients.

Karcz-Socha I, Zwirska-Korczala K, Zembala M, Borgiel-Marek H, Karcz K.

Obes Facts. 2011;4(5):386-92. doi: 10.1159/000334198. Epub 2011 Oct 21.

17.

[Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].

Vasil'eva MP, Rudenko TE, Kutyrina IM, Solomakhina NI.

Ter Arkh. 2015;87(6):17-22. Russian.

PMID:
26281190
18.
19.

High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey.

Heesen WF, Beltman FW, May JF, Smit AJ, de Graeff PA, Havinga TK, Schuurman FH, van der Veur E, Hamer JP, Meyboom-de Jong B, Lie KI.

Hypertension. 1997 Feb;29(2):539-43.

20.

Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients.

Lacchini R, Jacob-Ferreira AL, Luizon MR, Gasparini S, Ferreira-Sae MC, Schreiber R, Nadruz W Jr, Tanus-Santos JE.

J Hum Hypertens. 2012 Mar;26(3):171-7. doi: 10.1038/jhh.2011.8. Epub 2011 Feb 10.

PMID:
21307882

Supplemental Content

Support Center